Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Albrecht · SciRah

Researcher profile · Semantic Scholar

L. Albrecht

Share profile

L. Albrecht — researcher profile on SciRah

h-index: 10
Works: 35
Citations: 489

Most-cited papers

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial
A. Blauvelt, K. Papp, A. Gottlieb, A. Jarell +137 more
2019British Journal of Dermatology125 citations Open access
Semantic Scholar
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
M. Lebwohl, L. Kircik, A. Moore, L. S. Stein Gold +22 more
2022Journal of the American Medical Association (JAMA)101 citations Open access
Semantic Scholar
Economic burden of moderate to severe plaque psoriasis in Canada
A. Levy, A. Davie, Nicole C. Brazier, F. Jivraj +3 more
2012International Journal of Dermatology60 citations
Semantic Scholar
EFFICACY AND SAFETY OF APREMILAST IN PATIENTS WITH MILD TO MODERATE PLAQUE PSORIASIS: RESULTS OF A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.
L. S. Gold, K. Papp, D. Pariser, L. Green +8 more
2021Journal of American Academy of Dermatology48 citations Open access
Semantic Scholar
Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: a 52-week, phase 2, open-label trial.
L. S. Stein Gold, David N. Adam, L. Albrecht, J. Alonso‐Llamazares +17 more
2024Journal of American Academy of Dermatology21 citations
Semantic Scholar
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis
Gurbir Dhadwal, L. Albrecht, R. Gniadecki, Y. Poulin +3 more
2018Journal of Cutaneous Medicine and Surgery21 citations Open access
Semantic Scholar
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document
M. Gooderham, C. Hong, L. Albrecht, R. Bissonnette +13 more
2018Journal of Cutaneous Medicine and Surgery13 citations Open access
Semantic Scholar
Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations
L. Albrecht, M. Bourcier, J. Ashkenas, K. Papp
2011Journal of Cutaneous Medicine and Surgery13 citations
Semantic Scholar
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis
C. Hong, M. Gooderham, L. Albrecht, R. Bissonnette +13 more
2018Journal of Cutaneous Medicine and Surgery11 citations Open access
Semantic Scholar
Current Understanding of Seborrheic Dermatitis: Epidemiology, Burden of Disease, and Pathophysiology
I. Turchin, L. Albrecht, S. Hanna, Dimitrios Kyritsis +10 more
2025Journal of Cutaneous Medicine and Surgery10 citations
Semantic Scholar
Current Understanding of Seborrheic Dermatitis: Treatment Options
I. Turchin, L. Albrecht, S. Hanna, Dimitrios Kyritsis +10 more
2025Journal of Cutaneous Medicine and Surgery9 citations
Semantic Scholar
Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America
K. Papp, M. Gooderham, J. Beecker, C. Lynde +9 more
2019BMC Dermatology9 citations Open access
Semantic Scholar
Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting
K. Papp, M. Gooderham, L. Albrecht, Manon Raymond +1 more
2021British Journal of Dermatology8 citations Open access
Semantic Scholar
Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp or approximately 250 cm2 on the chest: a Phase III randomized controlled trial.
C. W. Hanke, L. Albrecht, T. Skov, T. Larsson +2 more
2020Journal of American Academy of Dermatology8 citations
Semantic Scholar
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones
A. McMichael, Mona Shahriari, L. S. Stein Gold, T. Alkousakis +22 more
2025JAMA dermatology6 citations
Semantic Scholar
Current Understanding of Seborrheic Dermatitis: Presentation, Diagnosis, and Special Populations
I. Turchin, L. Albrecht, S. Hanna, Dimitrios Kyritsis +10 more
2025Journal of Cutaneous Medicine and Surgery6 citations
Semantic Scholar
Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry
K. Papp, M. Gooderham, C. Lynde, Danielle Brassard +13 more
2024Archives of Dermatological Research6 citations Open access
Semantic Scholar
CUTANEOUS ENDOMETRIOSIS
L. Albrecht, V. Tron, J. Rivers
1995International Journal of Dermatology6 citations
Semantic Scholar
Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry
M. Gooderham, K. Papp, C. Lynde, I. Delorme +7 more
2022Dermatologic Therapy4 citations Open access
Semantic Scholar
Efficacy and Safety of Apremilast in Patients With Mild to Moderate Psoriasis Up to 32 Weeks: Results From the Extension Phase of the Randomized, Phase 3 ADVANCE Trial
L. S. Gold, K. Papp, D. Pariser, N. Bhatia +10 more
2022Journal of American Academy of Dermatology2 citations Open access
Semantic Scholar
Efficacy and Safety of Ingenol Mebutate Gel in Field Treatment of Actinic Keratosis on Full Face, Balding Scalp, or Approximately 250 cm2 on the Chest: A Phase III, Randomized, Controlled Trial
C. Hanke, L. Albrecht, Laerke K Kyhl, Thomas Larrson +2 more
20182 citations Open access
Semantic Scholar
Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis
L. Guenther, I. Turchin, R. Vender, L. Albrecht +3 more
2024Dermatologic Therapy1 citations Open access
Semantic Scholar
53822 Longitudinal evaluation of the psoriasis epidemiology screening tool (PEST) in patients with moderate to severe psoriasis: Results from the PURE Registry
L. Albrecht, J. Beecker, I. Delorme, I. Dei-Cas +7 more
2024Journal of American Academy of Dermatology1 citations
Semantic Scholar
Longitudinal Performance of the Psoriasis Epidemiology Screening Tool (PEST) in Canada and Latin America: Results from the Prospective, Observational, 5-Year PURE Registry
J. Beecker, L. Albrecht, I. Dei-Cas, M. Gooderham +8 more
2026Dermatologic Therapy0 citations Open access
Semantic Scholar
SA56 Canadian Expert Consensus on Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis
L. Guenther, V. Prajapati, R. Vender, L. Albrecht +4 more
2023Value in Health0 citations Open access
Semantic Scholar
35181 Baseline disease and population characteristics associated with a diagnosis of COVID 19: Data from the PURE registry
L. Albrecht, M. Gooderham, C. Lynde
2022Journal of American Academy of Dermatology0 citations Open access
Semantic Scholar
35158 Adaptations in the PURE registry in response to the COVID 19 pandemic: The impact of well-designed modifications in real-world data collection in a psoriasis registry
C. Lynde, K. Papp, J. Beecker, L. Albrecht +5 more
2022Journal of American Academy of Dermatology0 citations Open access
Semantic Scholar
28186 Efficacy and safety of tralokinumab monotherapy in North American adult patients with moderate-to-severe atopic dermatitis: A subanalysis of the ECZTRA 2 trial
M. Wiseman, A. Armstrong, J. Soung, L. Albrecht +2 more
20210 citations
Semantic Scholar
25996 Safety of tildrakizumab 100 mg and 200 mg through 5 years of exposure in reSURFACE 2
L. Albrecht, G. Han, W. Cantrell, A. Nguyen +2 more
20210 citations
Semantic Scholar
Supplemental Materials for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.
L. S. Gold, K. Papp, D. Pariser, L. Green +8 more
20210 citations
Semantic Scholar
Dermatologists' Perspectives on Defining Moderate Psoriasis: The Canadian Moderate Psoriasis Survey.
M. Gooderham, K. Papp, L. Albrecht, Parbeer S. Grewal +1 more
2021Journal of Drugs in Dermatology0 citations
Semantic Scholar
25423 Improvements in work productivity following baricitinib treatment in patients with moderate-to-severe atopic dermatitis: Results from BREEZE-AD5
L. Eichenfield, E. Maverakis, Jerry Tan, L. Albrecht +5 more
20210 citations
Semantic Scholar
Early and Maintained Response Levels in Psoriasis Patients Treated with Tildrakizumab
K. Papp, J. Yeung, N. Shear, L. Albrecht +6 more
2020SKIN The Journal of Cutaneous Medicine0 citations Open access
Semantic Scholar
Roflumilast Cream (ARQ-151) 0.15% and 0.3% Improved Burden of Signs and Symptoms in Adults With Chronic Plaque Psoriasis in a Phase 2b Study
L. Kircik, M. Lebwohl, K. Papp, M. Gooderham +12 more
20200 citations Open access
Semantic Scholar
An Open Letter to Health Canada
K. Papp, L. Albrecht, K. Barber, M. Bourcier +14 more
2017Journal of Cutaneous Medicine and Surgery0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Papp×22
Invite
K. Papp — researcher profile on SciRah
C. Lynde×18
Invite
C. Lynde — researcher profile on SciRah
M. Gooderham×14
Invite
M. Gooderham — researcher profile on SciRah
M. Wiseman×9
Invite
M. Wiseman — researcher profile on SciRah

×7

Invite

M. Gooderham — researcher profile on SciRah

Invite

I. Turchin — researcher profile on SciRah

Invite

I. Delorme — researcher profile on SciRah

V. Prajapati×6

Invite

V. Prajapati — researcher profile on SciRah

Invite

J. Beecker — researcher profile on SciRah

Invite

C. Hong — researcher profile on SciRah

Invite

D. Pariser — researcher profile on SciRah

Invite

I. Dei-Cas — researcher profile on SciRah